The regulation of cancer cell death and metabolism by extracellular matrix attachment

Seminars in Cell & Developmental Biology
Cassandra L BuchheitZachary T Schafer

Abstract

The metastasis of cancer cells to distant sites is responsible for the vast majority of cancer mortalities yet the molecular mechanisms underlying this extraordinarily complicated process have yet to be sufficiently elucidated. Recently, it has become clear that cancer cells need to inhibit anoikis, a cell death program induced by loss of attachment to the extracellular matrix (ECM), in order to successfully metastasize. These studies have motivated additional research into the relationship between ECM-detachment and cell viability, much of which reveals integral connections between ECM-detachment and cell metabolism. This review serves to thoroughly discuss the signaling pathways and metabolic changes that are induced by ECM-detachment. In addition, the molecular mechanisms by which cancer cells can alter signaling and metabolism to survive in the absence of ECM-attachment will be highlighted. Furthermore, cell death mechanisms that have been observed or implicated in cells detached from the ECM will also be examined. In aggregate, the studies discussed in this review reveal that ECM-detachment can regulate cancer cell metabolism in a variety of distinct cell types and suggest that interfering with metabolism in ECM-detached c...Continue Reading

References

May 1, 1992·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M DomingoM Reinacher
Jan 1, 1987·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·P Rodriguez-HorcheM Pinilla
Aug 1, 1973·European Journal of Biochemistry·J CarbonellA Sols
Jan 1, 1981·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·M Reinacher, E Eigenbrodt
Feb 1, 1994·The Journal of Cell Biology·S M Frisch, H Francis
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·U BrinckG Fischer
Sep 1, 1993·Molecular Biology of the Cell·J E MeredithM A Schwartz
Mar 18, 1999·Biochemical and Biophysical Research Communications·K Yamada, T Noguchi
Apr 6, 1999·Virchows Archiv : an International Journal of Pathology·P SteinbergE Eigenbrodt
Feb 22, 2001·Journal of the National Cancer Institute·R BosE van der Wall
Sep 7, 2001·Current Opinion in Cell Biology·S M Frisch, R A Screaton
Feb 24, 1956·Science·O WARBURG
Aug 10, 1956·Science·O WARBURG
Oct 1, 2003·Nature Genetics·Nobunao WakabayashiMasayuki Yamamoto
May 4, 2005·Molecular Cell·Russell G JonesCraig B Thompson
May 19, 2005·Molecular and Cellular Biology·Mauricio J ReginatoJoan S Brugge
Aug 17, 2005·Cancer Research·Thomas R Geiger, Daniel S Peeper
Jul 15, 2006·Cell·Karim BensaadKaren H Vousden
Jul 25, 2006·Cancer Biology & Therapy·Diane R Fels, Constantinos Koumenis
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniele GeneraliStephen B Fox
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tobias SchmelzleJoan S Brugge
Apr 19, 2007·Nature Reviews. Genetics·Don X Nguyen, Joan Massagué
Apr 5, 2008·Experimental Cell Research·Shih-Ching Lo, Mark Hannink
Apr 15, 2008·Nature Chemical Biology·Alexei DegterevJunying Yuan
May 20, 2008·Cell·Lai WangXiaodong Wang
Jun 10, 2008·Developmental Cell·Jing Yang, Robert A Weinberg
Jun 25, 2008·Current Opinion in Cell Biology·Rebecca Lock, Jayanta Debnath
Jun 27, 2008·Cancer Letters·Craig D SimpsonAaron D Schimmer
Sep 12, 2008·Nature Reviews. Molecular Cell Biology·Michael Overholtzer, Joan S Brugge
Sep 17, 2008·Biochemical Society Transactions·Lorenzo GalluzziGuido Kroemer
Nov 14, 2008·Cancer Letters·Katsuya TsuchiharaHiroyasu Esumi
Jan 16, 2009·Biochemical Society Transactions·Yu-Yun ChangThomas P Neufeld
Feb 10, 2009·Current Opinion in Genetics & Development·Xuemei TongCraig B Thompson
Feb 27, 2009·Nature Reviews. Cancer·Steven Christopher Smith, Dan Theodorescu
Mar 13, 2009·Nature Reviews. Cancer·Johanna A Joyce, Jeffrey W Pollard

❮ Previous
Next ❯

Citations

Feb 12, 2013·The International Journal of Biochemistry & Cell Biology·Fabienne MassaJean Mazella
Oct 14, 2014·Expert Opinion on Drug Discovery·Anton Yuryev
Feb 13, 2013·The Quarterly Review of Biology·Scott F GilbertAlfred I Tauber
Jun 12, 2013·International Journal of Cancer. Journal International Du Cancer·Shiwu ZhangJinsong Liu
Mar 24, 2016·Apoptosis : an International Journal on Programmed Cell Death·Yuqian ZhaoLingjuan Zhu
Oct 13, 2015·Oncogene·N Godin-HeymannJ Downward
Mar 10, 2015·Molecular Cancer·Zhenyi SuQiang Yu
Jul 9, 2013·Biochimica Et Biophysica Acta·Paolo PaoliPaola Chiarugi
Feb 14, 2015·The Journal of Infectious Diseases·Basim Al ShammariPaul T Elkington
Dec 20, 2014·Cell Death and Differentiation·C L BuchheitZ T Schafer
Jan 1, 2013·Cell Adhesion & Migration·Lívia C A RibeiroIracilda Z Carlos
Jan 16, 2015·Redox Biology·Laura Poillet-PerezMichaël Boyer-Guittaut
Nov 5, 2016·Biochimica Et Biophysica Acta·Maureen Redza-Dutordoir, Diana A Averill-Bates
Nov 12, 2016·International Journal of Molecular Sciences·Sophie Béraud-DufourJean Mazella
Mar 16, 2016·PLoS Genetics·Roberta PaloriniFerdinando Chiaradonna
May 5, 2017·Small GTPases·Joshua A Mason, Zachary T Schafer
May 16, 2017·Free Radical Biology & Medicine·Hila EmmertValerie G Brunton
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Tianzhen WangXiaobo Li
Dec 1, 2017·Scientific Reports·Samira Bernardino Ramos do PradoJoão Paulo Fabi
Jan 18, 2018·The Journal of Biological Chemistry·Mark A Hawk, Zachary T Schafer
Jan 25, 2018·Cell Death and Differentiation·Lorenzo GalluzziGuido Kroemer
Nov 21, 2019·Physical Biology·F Motahari, A E Carlsson
Feb 23, 2020·Antioxidants & Redox Signaling·James H Schofield, Zachary T Schafer
Apr 25, 2020·Cells·Samantha SarcognatoMaria Guido
Jul 3, 2020·Journal of Cellular and Molecular Medicine·Xiao-Shen ChengBayasi Guleng
Aug 8, 2014·Nature Reviews. Cancer·Cassandra L BuchheitZachary T Schafer
Aug 24, 2019·Scientific Reports·Chiara LiveraniEnnio Tasciotti
Mar 22, 2018·Molecular Diagnosis & Therapy·Abhay P MishraManisha Nigam
Aug 23, 2019·Cancers·Jordan A Cockfield, Zachary T Schafer
May 28, 2019·Molecular Cancer·Yitao GongChen Liu
Nov 17, 2020·Frontiers in Oncology·Wei-Ming LiChien-Feng Li
Jun 19, 2013·Cancer Research·Calli A DavisonZachary T Schafer

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.